The Global Digital Pathology Market is growing with the rapid pace; mainly due technologically advanced diagnostic tools for the chronic diseases such as cancer has upsurged the demand for digital pathology. According to a recent study report published by the Market Research Future, The global digital pathology market is booming and expected to gain prominence over the forecast period growing rapidly. The market is forecasted to demonstrate a spectacular growth by 2022, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2022).
With the evolution of information technology in the past few years, a rapid change has being observed in the practice of pathology. Various novel techniques have been implemented, primarily in the form of digital imaging and Telepathology (TP). Digital pathology is a branch which can be defined as the electronic capture, management, analysis and distribution of gross or microscopic specimens. It encompasses the use of digital imaging as well as TP. Digital pathology has a wide spectrum of applications that includes primary diagnosis, intraoperative diagnosis, consultation, quality assurance, archiving, research and academic studies. This technique helps in speeding up the process of diagnosis and further treatment. It also helps in research procedures by offering an easy access to the previously stored digital information. As per the Royal College of Pathologists, in the UK alone pathologists carry out 121,000 autopsies each year which has supported the market growth.
To Get PDF Sample Copy @ https://www.marketresearchfuture.com/sample_request/1955
The market is expected grow with the same trends during the forecast period. The major drivers will be rapid technological advancements in digital pathology system such as advancements in digital imaging, robotic light microscopy, and multiple fiber optic communications among others. Moreover, growing prevalence of chronic conditions, that has expected to uplift the demand for digital pathology in order to improve existing patient diagnostic imaging measures and reduce high cost associated with the traditional diagnostics methods. For instance, as per National Pathology Programme, nearly 800 million tests are being performed annually which is equal to 14 for each person in England and Wales. Additionally, increasing R&D applications of static and dynamic systems is fostering the market growth of digital pathology market.
Global Digital Pathology Market – Competitive Analysis
The market for digital pathology is characterised by the presence of several well-established and small players, the global market of digital pathology appears to be highly competitive and fragmented. Global players are increasingly expanding their footprint in the emerging nations, making it putting pressure on the regional players, especially in terms of features such as type, product portfolios, and pricing. The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. Well established players are entering into mergers & acquisitions, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position.
Companies like Leica Biosystems; Hamamatsu Photonics, Inc.; and Olympus Corporation are increasingly adopting extensive collaborative strategies to gain more profits and capturing new markets. For instance, in March 2017, Leica Biosystems entered into a strategic partnership with Leeds Hospital to improve productivity and workflow.
Key participants like Royal Philips has acquired the Irish PathXL, one of the largest pathology, image-based analysis firms in order to develop integrated tools targeting applications in computational biology, workflow solutions, education, and image analytics. In addition, these key activities the companies are aiming towards supporting the gradual transition of medical institutions present across the globe from the conventional pathology systems to digital pathology systems.
Thus, we can say that these competitive developments will further enable pathologists to perform high-throughput analysis of clinical image datasets that are diverse in nature and expedite improvement in the diagnosis quality, thereby presenting a potential for adoption new ad improved therapies to enhance patient health outcomes.
microDimensions GmbH (Germany), Mikroscan Technologies, Inc. (U.S.), Q2 Solutions (U.S.), Omnyx, LLC (U.S.), GE Healthcare (UK), Philips Healthcare (U.S.), Huron Digital Pathology Inc. (Canada), ViewsIQ Inc. (Canada), 3DHISTECH Ltd (Hungary) Apollo Enterprise Imaging Corp. (U.S.), Xifin Inc. (U.S.), Definiens (Germany) and others. are some of the prominent players at the forefront of competition in the Global Digital Pathology Market and are profiled in MRFR Analysis.
Industry Updates:
In December 2018, OptraSCAN, a provider of on-demand digital pathology, has collaborated with Deenanath Mangeshkar Hospital and Research Centre to deploy OptraSCAN’s affordable digital pathology solution equipped with artificial intelligence and machine learning technologies.
In December 2018, Inspirata, a Europe based cancer informatics and digital pathology workflow solution provider, has entered into a partnership with Hamamatsu Photonics, a Japanese manufacturer of optical sensors, electric light sources and other devices for scientific and medical use.
Global Digital Pathology Market – Segmentation
The global digital pathology market is segmented on the basis of type, product, application, and end-users. Based on type, the global digital pathology market is segmented into human pathology and animal pathology. The human pathology segment commands for the major share of 65% in the global digital pathology market due to the high prevalence of chronic diseases among humans. This segment is projected to reach the valuation of USD 5,475.4 Mn by the end of 2023. Based on product, the global digital pathology market has been segmented into hardware, software, and storage. The hardware segment commands for the maximum share of the global digital pathology market and is anticipated to reach the valuation of USD 6,031.9 Mn by the end of 2023.
Based on application, the global digital pathology market is segmented into disease diagnosis, Mhealth, drug discovery, and telemedicine. The disease diagnosis segment is leading the global digital pathology market with the valuation of USD 2,650 Mn by the end of the forecast period. Based on end-users, the global digital pathology market has been segmented into hospital & clinic, diagnostic centers, and research centers & academic institutes. The research centers and academic institutes segment is expanding at the fastest growth rate in the global digital pathology market and is anticipated to reach the valuation of USD 3,778.4 Mn by the end of the assessment period.
Browse Complete Report @ https://www.marketresearchfuture.com/reports/digital-pathology-market-1955
Global Digital Pathology Market – Regional Analysis
Geographically, the global digital pathology market is segmented into four major regions such as the Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas has emerged as a leading region in the global digital pathology market owing to the increased adoption of technologically advanced solutions in the healthcare sector for accurate and faster diagnosis, high prevalence of chronic diseases and increased healthcare expenditure by the population in this region. Presence of large number of major players and increased research and development for the introduction of advanced diagnostic techniques in the well-developed healthcare sector are fueling the growth of the global digital pathology market in the Europe region. The Asia Pacific region is expanding at the highest CAGR of 13.53% during the assessment period owing to the increasing healthcare expenditure and rapid development of healthcare sector in the emerging economies of this region. Lack of awareness and absence of primary healthcare facilities are resulting in the poor growth of the digital pathology market in the Middle East and Africa region.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Hadapsar, Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312